THERATEST EL-BETA2GPI (IGM-IGG-IGA), THERATEST EL--BETA2GPI SCR

System,test,antibodies,b2 - Glycoprotein I (b2 - Gpi)

THERA-TEST LABORATORIES INC.

The following data is part of a premarket notification filed by Thera-test Laboratories Inc. with the FDA for Theratest El-beta2gpi (igm-igg-iga), Theratest El--beta2gpi Scr.

Pre-market Notification Details

Device IDK092757
510k NumberK092757
Device Name:THERATEST EL-BETA2GPI (IGM-IGG-IGA), THERATEST EL--BETA2GPI SCR
ClassificationSystem,test,antibodies,b2 - Glycoprotein I (b2 - Gpi)
Applicant THERA-TEST LABORATORIES INC. 1111 N. MAIN ST. Lombard,  IL  60148
ContactMarius Teodorescu
CorrespondentMarius Teodorescu
THERA-TEST LABORATORIES INC. 1111 N. MAIN ST. Lombard,  IL  60148
Product CodeMSV  
CFR Regulation Number866.5660 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeSpecial
3rd Party ReviewedNo
Combination ProductNo
Date Received2009-09-09
Decision Date2009-10-09

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00854473003286 K092757 000
00854473003040 K092757 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.